TrialJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2012

A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease.

Bruce M Prenner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.